EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparison of Short-Term Post-Thymectomy Outcomes by Time-Weighted Dosages of Drug Requirements between Thymoma and Non-Thymoma Myasthenia Gravis Patients

Phattamon Wiboonpong, Suwanna Setthawatcharawanich, Pat Korathanakhun, Thanyalak Amornpojnimman, Nannapat Pruphetkaew, Pensri Chongphattararot, Chutarat Sathirapanya iD, Pornchai Sathirapanya iD

International Journal of Environmental Research and Public Health · 2023

DOI: 10.3390/ijerph20043039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, 2023. Verfasst von Phattamon Wiboonpong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand. Hauptthemen laut MEDLINE: Thymus Neoplasms, Myasthenia Gravis. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Early thymectomy is suggested in all clinically indicated myasthenia gravis (MG) patients. However, short-term clinical response after thymectomy in MG patients has been limitedly described in the literature. This study aimed to compare the 5-year post-thymectomy outcomes between thymoma (Th) and non-thymoma (non-Th) MG patients. (2)

Methods

MG patients aged ≥18 years who underwent transsternal thymectomy and had tissue histopathology reports in Songklanagarind Hospital between 2002 and 2020 were enrolled in a retrospective review. The differences in the baseline demographics and clinical characteristics between ThMG and non-Th MG patients were studied. We compared the time-weighted averages (TWAs) of daily required dosages of pyridostigmine, prednisolone or azathioprine to efficiently maintain daily living activities and earnings between the MG patient groups during 5 consecutive years following thymectomy. Post-thymectomy clinical status, exacerbations or crises were followed. Descriptive statistics were used for analysis with statistical significance set at p < 0.05. (3)

Results

ThMG patients had significantly older ages of onset and shorter times from the MG diagnosis to thymectomy. Male gender was the only significant factor associated with ThMG. TWAs of the daily MG treatment drug dosages required showed no differences between the groups. Additionally, the rates of exacerbations and crises were not different, but decremental trends were shown in both groups after the thymectomies. (4)

Conclusions

The daily dosage requirements of MG treatment drugs were not different. There was a trend of decreasing adverse event rates despite no statistically significant differences during the first 5 years after thymectomy in ThMG and non-ThMG patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thymus NeoplasmsMyasthenia GravisHumansMaleAdolescentAdultThymectomyPyridostigmine BromideRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

crisisexacerbationmyasthenia gravisthymectomythymoma

Substanzen

Pyridostigmine Bromide

Autor:innen und Institutionen

  • Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  • Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  • Department of Family and Preventive Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.

ORCID-Profile: Chutarat Sathirapanya, Pornchai Sathirapanya

Zitieren

APA

Wiboonpong, P., Setthawatcharawanich, S., Korathanakhun, P., Amornpojnimman, T., Pruphetkaew, N., Chongphattararot, P., Sathirapanya, C., & Sathirapanya, P. (2023). Comparison of Short-Term Post-Thymectomy Outcomes by Time-Weighted Dosages of Drug Requirements between Thymoma and Non-Thymoma Myasthenia Gravis Patients. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph20043039

Vancouver

Wiboonpong P, Setthawatcharawanich S, Korathanakhun P, Amornpojnimman T, Pruphetkaew N, Chongphattararot P, et al. Comparison of Short-Term Post-Thymectomy Outcomes by Time-Weighted Dosages of Drug Requirements between Thymoma and Non-Thymoma Myasthenia Gravis Patients. International Journal of Environmental Research and Public Health. 2023. doi:10.3390/ijerph20043039

BibTeX
@article{Wiboonpong2023,
  author = {Wiboonpong, Phattamon and Setthawatcharawanich, Suwanna and Korathanakhun, Pat and Amornpojnimman, Thanyalak and Pruphetkaew, Nannapat and Chongphattararot, Pensri and Sathirapanya, Chutarat and Sathirapanya, Pornchai},
  title = {Comparison of Short-Term Post-Thymectomy Outcomes by Time-Weighted Dosages of Drug Requirements between Thymoma and Non-Thymoma Myasthenia Gravis Patients},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2023},
  doi = {10.3390/ijerph20043039}
}
Kostenlos starten →